JP2015508094A - Ｄｇｌａ、１５−ｏｈｅｐａ、及び／又は１５−ｈｅｔｒｅを含む医薬組成物並びにこれを使用する皮脂生成の低減法 - Google Patents

Ｄｇｌａ、１５−ｏｈｅｐａ、及び／又は１５−ｈｅｔｒｅを含む医薬組成物並びにこれを使用する皮脂生成の低減法 Download PDF

Info

Publication number
JP2015508094A
JP2015508094A JP2014558140A JP2014558140A JP2015508094A JP 2015508094 A JP2015508094 A JP 2015508094A JP 2014558140 A JP2014558140 A JP 2014558140A JP 2014558140 A JP2014558140 A JP 2014558140A JP 2015508094 A JP2015508094 A JP 2015508094A
Authority
JP
Japan
Prior art keywords
weight
pharmaceutical composition
dgla
hetre
ohepa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014558140A
Other languages
English (en)
Japanese (ja)
Inventor
コウグフラン デイブ
コウグフラン デイブ
ドウネス ビル
ドウネス ビル
クリマクス ジョン
クリマクス ジョン
マンク メハル
マンク メハル
Original Assignee
ディグニティ サイエンシス リミテッド
ディグニティ サイエンシス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ディグニティ サイエンシス リミテッド, ディグニティ サイエンシス リミテッド filed Critical ディグニティ サイエンシス リミテッド
Publication of JP2015508094A publication Critical patent/JP2015508094A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2014558140A 2012-02-23 2013-02-25 Ｄｇｌａ、１５−ｏｈｅｐａ、及び／又は１５−ｈｅｔｒｅを含む医薬組成物並びにこれを使用する皮脂生成の低減法 Pending JP2015508094A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261602374P 2012-02-23 2012-02-23
US61/602,374 2012-02-23
PCT/EP2013/053677 WO2013124479A1 (en) 2012-02-23 2013-02-25 Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of reducing sebum production using same

Publications (1)

Publication Number Publication Date
JP2015508094A true JP2015508094A (ja) 2015-03-16

Family

ID=47915154

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014558140A Pending JP2015508094A (ja) 2012-02-23 2013-02-25 Ｄｇｌａ、１５−ｏｈｅｐａ、及び／又は１５−ｈｅｔｒｅを含む医薬組成物並びにこれを使用する皮脂生成の低減法

Country Status (6)

Country Link
US (3) US20130267598A1 (enrdf_load_stackoverflow)
EP (1) EP2817005A1 (enrdf_load_stackoverflow)
JP (1) JP2015508094A (enrdf_load_stackoverflow)
CN (1) CN104244941A (enrdf_load_stackoverflow)
IN (1) IN2014DN07483A (enrdf_load_stackoverflow)
WO (1) WO2013124479A1 (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018524274A (ja) * 2015-05-13 2018-08-30 ディーエス バイオファーマ リミテッド １５−オキソ−ｅｐａまたは１５−オキソ−ｄｇｌａを含む組成物、ならびにその作製及び使用方法
US12076304B2 (en) 2020-04-03 2024-09-03 Afimmune Limited Compositions comprising 15-HEPE and methods of treating or preventing hematologic disorders, and/or related diseases
US12274685B2 (en) 2015-12-18 2025-04-15 Afimmune Limited Compositions comprising 15-HEPE and methods of using the same

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
GB201301626D0 (en) 2013-01-30 2013-03-13 Dignity Sciences Ltd Composition comprising 15-OHEPA and methods of using the same
WO2015071766A1 (en) 2013-11-15 2015-05-21 Dignity Sciences Limited Pharmaceutically acceptable salts of polyunsaturated hydroxy fatty acids
RU2019110980A (ru) * 2014-01-10 2019-08-26 Эфиммьюн Лимитед Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
MA39718A (fr) * 2014-04-09 2017-02-15 Dignity Sciences Ltd Compositions et méthodes d'utilisation de celles-ci
RU2020101477A (ru) 2014-06-04 2020-06-19 Дигнити Сайенсиз Лимитед Фармацевтические композиции, содержащие дглк, и их применение
MA41120A (fr) 2014-12-02 2017-10-10 Afimmune Ltd Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci
US20170020836A1 (en) 2015-07-21 2017-01-26 Dignity Sciences Limited Compositions Comprising 15-HEPE and Methods of Treating or Preventing Cancer and Neurologic Disease
CN115215725A (zh) * 2021-04-15 2022-10-21 宋晓瑜 一种制备乙酸薰衣草酯及薰衣草醇的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
DE10121252A1 (de) * 2001-04-30 2002-11-07 Christos C Zouboulis Behandlung der Akne
GB0611240D0 (en) * 2006-06-07 2006-07-19 Daniolabs Ltd The treatment of increased sebum production
FR2906716B1 (fr) 2006-10-06 2013-05-17 Clarins Lab Utilisation d'une composition cosmetique pour le soin des peaux grasses.
ITMI20070555A1 (it) * 2007-03-21 2007-06-20 Giuliani Spa Composizione provvista di attivita' di inibizione sulla 5 alfa-reduttasi
US8293790B2 (en) * 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018524274A (ja) * 2015-05-13 2018-08-30 ディーエス バイオファーマ リミテッド １５−オキソ−ｅｐａまたは１５−オキソ−ｄｇｌａを含む組成物、ならびにその作製及び使用方法
JP2021075563A (ja) * 2015-05-13 2021-05-20 ディーエス バイオファーマ リミテッド １５−オキソ−ｅｐａまたは１５−オキソ−ｄｇｌａを含む組成物、ならびにその作製及び使用方法
JP7229285B2 (ja) 2015-05-13 2023-02-27 ディーエス バイオファーマ リミテッド １５－オキソ－ｅｐａまたは１５－オキソ－ｄｇｌａを含む組成物、ならびにその作製及び使用方法
US12017986B2 (en) 2015-05-13 2024-06-25 Ds Biopharma Limited Compositions comprising oxo-derivatives of fatty acids and methods of making and using same
US12274685B2 (en) 2015-12-18 2025-04-15 Afimmune Limited Compositions comprising 15-HEPE and methods of using the same
US12076304B2 (en) 2020-04-03 2024-09-03 Afimmune Limited Compositions comprising 15-HEPE and methods of treating or preventing hematologic disorders, and/or related diseases

Also Published As

Publication number Publication date
EP2817005A1 (en) 2014-12-31
CN104244941A (zh) 2014-12-24
US20150094370A1 (en) 2015-04-02
IN2014DN07483A (enrdf_load_stackoverflow) 2015-04-24
US20130274338A1 (en) 2013-10-17
WO2013124479A1 (en) 2013-08-29
US20130267598A1 (en) 2013-10-10

Similar Documents

Publication Publication Date Title
JP2015508094A (ja) Ｄｇｌａ、１５−ｏｈｅｐａ、及び／又は１５−ｈｅｔｒｅを含む医薬組成物並びにこれを使用する皮脂生成の低減法
US8293790B2 (en) Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US8679552B2 (en) Acne vulgaris treatment regimen
KR101018352B1 (ko) 봉독을 유효성분으로 하는 여드름 예방 및 치료용 조성물
JP6810201B2 (ja) 炎症性疾患用皮膚外用組成物
JP2016527307A (ja) 胆汁酸−脂肪酸抱合体を含む抗座瘡組成物
CN110035797A (zh) 用于治疗痤疮的局部组合物
CN102038672B (zh) 一种用于治疗痤疮的药物组合物
JP2014144929A (ja) ビタミン類を含有するニキビの予防又は治療用組成物
CN115475135B (zh) 用于控制皮肤常驻菌群的组合物
JP2018002651A (ja) 慢性角化型湿疹改善剤
JP2018002652A (ja) 慢性角化型湿疹改善剤
JP2017510596A (ja) 皮膚病態を治療するための組成物
HK1224943A1 (en) Anti-acne compositions comprising bile acid-fatty acid conjugates
TW201536335A (zh) 脂肪酸於減少與類視色素治療相關之皮膚刺激的用途